ZRG Partners says there was a “fight for talent” in hiring, firing and vacancies in Q2, with the outsourcing and pharmaceutical sectors battling for employees within regulatory, quality and clinical roles.
A 38 per cent increase in revenues helped PDI cut its operating loss to $1.7m (€1.3m) in the first quarter, furthering the contract sales provider’s goal of achieving profitability by the end of the year.
MLawGroup and WS Partners are collaborating to offer pharma and biotech advisory services, including help in preparing and negotiating agreements with CROs and CMOs.
Communication is a vital aspect of the relationship between CMOs, CROs and their clients, with a single point of contact who quickly informs sponsors of problems a necessity, according to a panel at Informex 2010.
Contract services major Quintiles will sell Movetis’ chronic constipation treatment Resolor (prucalopride) in Europe under a contract announced last week.
inVentiv Health has rolled-out FlightPath, a new bespoke service designed to help pharmaceutical and biotechnology companies chart a clear course to commercial launch.
The drug industry must “fundamentally change” how it sells products and make greater use of advanced analytics to measure performance, according to a report by Deloitte Consulting.
Symphony Metro Pharma Solutions and HP Solutions have created a new application that, they claim, can help drug marketeers identify activities with the greatest revenue potential.
Axiom Accelerated Patient Recruitment hopes its new range of SMS, text messaging, services can help CROs and pharma sponsors reach more potential study participants.
Market intelligence giant IMS Health has extended its KPO market and sales analytics offering and signed a new collaboration deal with Indian IT contracting group Tata Consultancy Services (TCS).
Synexus is meeting the rising demand for its services, which it says can dramatically increase recruitment rates, by acquiring clinical trial sites in Poland and is hoping to expand in India soon.
US software group SourceSolution has signed a co-marketing deal with bioProcessUK they claim will help UK pharma contractors raise their global profiles and find new drug industry clients.
inVentiv Health is expanding it REMS-related services, which it believes is a growth area, using its experience in risk management to help clients formulate strategies.
US contract services firm Norwich Pharmaceuticals has teamed up with Emerson Resources in a partnership that both claim will help drug industry partners bring products to market.
PDI posted a larger operating loss in Q1 2009 than in the previous year, with the company blaming the decline on the expiration, termination and postponement of contracts.
The US contract manufacturing sector is strong enough to bounce back from any short-term slow down caused by the credit crisis, according to a new report by Frost & Sullivan (F&S).
United Drug’s contract packaging business is expected to report a significant dip in profits but strong performance in the sales division helped push up its share price.
The global economic downturn, impending blockbuster patent expiries and the wave of consolidation sweeping the pharmaceutical industry will drive demand for Patheon’s restructuring service according to CEO Wesley Wheeler.
Drug contract services specialist inVentive Health has selected a new office in Somerset, New Jersey, US which will house its patient outcomes, clinical, health and commercial division.
inVentive Health has been contracted to provide marketing and branding services for fellow US based generic injectables developer GeneraMedix, specifically focusing on the latter’s epoprostenol hypertension treatment.
DPT Laboratories chose this year’s AAPS in Atlanta to showcase its research and development capability with a unique poster presentation examining the role of various excipients in nasal drug delivery applications.
The pharmaceutical industry must adapt its processes and strategies to cope with a new, tougher operating environment, according to Stefan Borgas, CEO of Lonza.
After months of deliberations, a court in Iowa has opted to fine contract manufacturing company Cambrex $6,000 for safety violations after an explosion at its facility in Charles City.
Pfizer is shifting its research focus to those diseases where its sees the potential for the biggest treatment improvements and profits, while dropping eight disease areas including cholesterol.
Indian pharmaceutical companies are making their first forays in the biotechnology arena, helping the market expand from a standing start at the beginning of the decade to reach a value of $2bn in 2006-7, according to a recent report from KPMG.
Outsourcing-Pharma.com presents its latest round-up of new appointments, employment moves and personnel news in the pharmaceutical contract services sector.
Outsourcing-Pharma.com presents its latest round-up of new appointments, employment moves and personnel news in the pharmaceutical contract services sector.
Outsourcing-Pharma.com presents its periodic round-up of personnel changes in the pharmaceutical outsourcing arena, with senior appointments at Bristol-Myers Squibb, Parexel and GVK Bio, amongst others.
Pharmaceutical companies in the developed world have already
shifted substantial manufacturing and clinical trial work to
emerging economies such as China and India, but a new study suggest
they are increasingly counting on these...
Pfizer has enlisted outsourcing services firm NovaMed
Pharmaceuticals to conduct the distribution, sales and marketing of
some of its products in the country.
Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...
